Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 
 

News

 

SAVE-US Pivotal Trial Begins for Bluegrass Vascular's Surfacer Inside-Out Device

January 18, 2018 -- Bluegrass Vascular Technologies, Inc. announced the enrollment of the first patients in the SAVE-US (Surfacer System to Facilitate Access in Venous Occlusi…

BD Announces Completion of Enrollment in the Lutonix 014 DCB BTK Trial

January 18, 2018 -- BD Interventional announced the completion of enrollment in the Lutonix below-the-knee (BTK) trial. BD plans to submit a premarket approval application in …

Pivotal Trial of Laminate's VasQ Device Begins in the United States

January 18, 2018 -- Laminate Medical Technologies announced the launch of its United States pivotal study for the company's VasQ implanted blood vessel external suppo…

AHA Announces Strategically Focused Research Network for Vascular Disease

January 16, 2018 -- The American Heart Association (AHA) recently announced that scientific teams have been selected that will lead a new AHA-funded research network dedicated…

Angiosome-Targeted Infrapopliteal Balloon Angioplasty in Patients With CLI

January 16, 2018 -- Online in European Journal of Vascular and Endovascular Surgery (EJVES), Ahmed Elbadawy, MD, et al published findings from a prospective study evaluating c…

French WINDOW Trial Investigators Evaluate Cost-Effectiveness of Fenestrated/Branched EVAR for Complex Aortic Aneurysms

January 16, 2018 -- Two-year results from a study of the cost-effectiveness of fenestrated/branched endovascular aneurysm repair (f/b EVAR) compared with open surgical repair …

Click here for more News coverage

Current Supplement

Sponsored by NUCRYO VASCULAR, LLC

Next-Generation Cryoplasty®

Experts discuss the benefits, data, reimbursement, and clinical utility of the PolarCath™ Balloon Dilatation System.

Fall Supplement

Sponsored by BTG INTERNATIONAL

Setting the Standard in VTE

Exploring new data in the treatment of DVT and PE.

Featured Center

 

Embolization

advertisement

 
Vascular Market Price  Change
Abbott Laboratories $59.32  0.55%
AstraZeneca PLC $35.45  1.04%
Avinger $0.20  1.60%
Boston Scientific Corporation $27.65  1.45%
BTG plc $758.50  3.48%
Cardinal Health $71.96  -0.95%
Cardiovascular Systems Inc. $25.97  -1.05%
Edwards Lifesciences Corp. $123.96  2.88%
Endologix Inc. $4.36  2.71%
Vascular Market Price  Change
Johnson and Johnson $147.38  0.27%
Medtronic, Inc. $86.67  0.65%
Merit Medical Systems, Inc. $47.98  2.51%
Penumbra, Inc. $91.30  2.07%
Philips $41.04  2.54%
Stryker $161.36  0.68%
Teleflex Inc. $276.52  1.54%
The Medicines Company $24.85  -2.05%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.